Comprehensive DNA methylation analysis of human neuroblastoma cells treated with blonanserin

详细信息    查看全文

• 作者：Yui Murata^a ; ^b ; Masaki Nishioka^a ; ^b ; Miki Bundo^a ; Fumiko Sunaga^a ; Kiyoto Kasai^b ; Kazuya Iwamoto^a ; ^{kaziwamoto-tky@umin.ac.jp" class="auth_mail}
• 关键词：DRD2 ; dopamine receptor 2 ; GWAS ; genome-wide association study ; HDAC2 ; histone deacetylase 2 ; HTR2A ; serotonin receptor 2A ; mGluR2 ; metabotropic glutamate receptor 2 ; PCA ; principle component analysis
• 刊名：Neuroscience Letters
• 出版年：20 March, 2014
• 年：2014
• 卷：563
• 期：Complete
• 页码：123-128
• 全文大小：505 K

文摘

Blonanserin is a second-generation antipsychotic drug for schizophrenia. The pharmacological actions of blonanserin are shown to be the antagonism of dopamine receptor 2 and serotonin receptors. However, its molecular mechanisms in brain cells have not been fully characterized. Accumulating evidence suggests that antipsychotic drugs and mood stabilizers show epigenetic effects on a wide range of genes in animal and cellular models. We performed genome-wide DNA methylation analysis targeting 479,814 CpG sites of cultured human neuroblastoma cells administered with blonanserin. We found that 3,057 CpG sites showed statistically significant changes in DNA methylation at two different doses of blonanserin (1.36 nM and 13.6 nM). These included hypermethylated CpG sites that were enriched in genes related to axonogenesis and cell morphogenesis involved in neuron differentiation. We also showed that the global effect on DNA methylome depends on the concentration of the drug. With a high dose of blonanserin, the overall methylation levels across all CpG sites significantly increased. These increases in DNA methylation were prominent in the CpG sites distant from promoter regions. We further examined DNA methylation changes in specific genes implicated for the actions of antipsychotic drugs, such as the dopamine receptor 2 (DRD2) gene and the serotonin receptor 2A (HTR2A) gene. We observed that CpG sites that were located within DRD2 and HTR2A genes were significantly hypermethylated by blonanserin. The DNA methylation changes induced by the treatment with blonanserin will be useful for understanding its pharmacological actions at the cellular level